Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
199.5 USD -0.65% Intraday chart for STERIS plc -2.20% -9.25%
Sales 2024 * 5.46B Sales 2025 * 5.77B Capitalization 19.71B
Net income 2024 * 544M Net income 2025 * 652M EV / Sales 2024 * 4.15 x
Net Debt 2024 * 2.94B Net Debt 2025 * 2.41B EV / Sales 2025 * 3.83 x
P/E ratio 2024 *
36.5 x
P/E ratio 2025 *
29 x
Employees 17,000
Yield 2024 *
1.02%
Yield 2025 *
1.12%
Free-Float 99.73%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.65%
1 week-2.20%
Current month-11.26%
1 month-13.31%
3 months-9.90%
6 months-8.02%
Current year-9.25%
More quotes
1 week
197.82
Extreme 197.82
207.86
1 month
197.82
Extreme 197.82
235.00
Current year
197.82
Extreme 197.82
238.51
1 year
180.54
Extreme 180.54
254.00
3 years
159.21
Extreme 159.21
255.93
5 years
105.69
Extreme 105.69
255.93
10 years
47.24
Extreme 47.24
255.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 18-07-31
Director of Finance/CFO 56 14-01-31
Investor Relations Contact - 04-04-30
Members of the board TitleAgeSince
Director/Board Member 74 08-03-31
Director/Board Member 74 03-09-30
Director/Board Member 58 20-07-27
More insiders
Date Price Change Volume
24-04-19 199.5 -0.65% 535,935
24-04-18 200.8 +0.28% 658,479
24-04-17 200.2 +0.62% 1,115,554
24-04-16 199 -1.09% 784,627
24-04-15 201.2 -1.37% 847,866

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals); - development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide; - manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers. Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%). Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
199.5 USD
Average target price
238.2 USD
Spread / Average Target
+19.38%
Consensus